Inscripta

Inscripta is a biotechnology company whose current official website announces that it is “now Manus.” The site says Inscripta has joined forces with Manus to accelerate the transition to BioAlternatives and describes Manus as working to scale biology to replace ingredients, materials, and products associated with the fossil age. It presents this work as a way to build more resilient and sustainable supply chains. The website indicates that Inscripta’s identity and web presence are transitioning to Manus, and says visitors will be redirected to manus.bio. It also specifically directs people with questions about Inscripta’s MAD7 licensing to madzymes.com. The available evidence does not establish Inscripta’s founding date, headquarters, founders, ownership structure, product portfolio beyond the licensing reference, or geographic markets.

The available evidence provides only a limited account of Inscripta’s history. Its current official website announces “Inscripta is now Manus” and says the organizations have joined forces to accelerate the transition to BioAlternatives. The site frames Manus’s work as scaling biology to replace ingredients, materials, and products associated with the fossil age, while building more resilient and sustainable supply chains. The announcement indicates a change in Inscripta’s public-facing identity and web destination: visitors are told they will be redirected to manus.bio. However, the supplied evidence does not specify when this change took place, the legal or financial structure behind the joining of forces, or whether it constitutes an acquisition, merger, or another arrangement. Accordingly, no precise transaction or ownership claim can be made from this evidence. Inscripta’s official homepage retains a specific reference to MAD7 licensing. It directs visitors with questions about that licensing program to madzymes.com, showing that this licensing-related contact remains relevant to the Inscripta name. The evidence does not describe the technology, licensing terms, product specifications, or the history of MAD7. No supported information is supplied here about Inscripta’s founding, founders, headquarters, leadership, earlier milestones, or geographic reach. The history should therefore be understood as a concise account of the transition stated on the current official website, rather than a complete corporate chronology.

• Inscripta announces it is now Manus

  [1]Inscripta is now Manusinscripta.com

The current website associates Inscripta with Manus’s stated effort to scale biology and develop BioAlternatives intended to replace fossil-derived ingredients, materials, and products.

• MAD7 licensing

  The official website directs questions about Inscripta’s MAD7 licensing to madzymes.com; further product and licensing details are not provided in the supplied evidence.

• Join forces with Manus and transition the web presenceOther

  Source

1. 1Inscripta is now Manusinscripta.com
2. 2Inscripta, Inc.wikidata.org